Natural products in traditional Chinese medicine for renal fibrosis: a comprehensive review

Renal fibrosis represents the terminal pathological manifestation of most chronic kidney diseases, driving progressive loss of renal function. Natural products have emerged as promising therapeutic agents for preventing and ameliorating renal fibrosis due to their multi-target efficacy and favorable...

Full description

Saved in:
Bibliographic Details
Published inFrontiers in pharmacology Vol. 16; p. 1560567
Main Authors Zhao, Qianqian, Jin, Meihua, Zhao, Qiang, Wang, Zhimei, Zhao, Chun, Xue, Xiaocong, Qiao, Xikai, Qu, Peng, Han, Donghe, Tao, Ran
Format Journal Article
LanguageEnglish
Published Switzerland Frontiers Media S.A 16.04.2025
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Renal fibrosis represents the terminal pathological manifestation of most chronic kidney diseases, driving progressive loss of renal function. Natural products have emerged as promising therapeutic agents for preventing and ameliorating renal fibrosis due to their multi-target efficacy and favorable safety profiles. In this review, we conducted a comprehensive literature search on PubMed using the keywords “natural product” and “renal fibrosis” from 2004 to 2025, identifying 704 relevant articles. We systematically categorize and discuss the biological effects of key natural products and formulations with antifibrotic potential, focusing on five major classes: glycosides, flavonoids, phenolic compounds, anthraquinones, and terpenoids. Representative compounds from each category are highlighted for their mechanisms of action, including modulation of oxidative stress, inflammation, autophagy, and fibrosis signaling pathways. This review aims to provide a theoretical foundation for the development of natural product-based therapies to combat renal fibrosis, offering insights into their therapeutic potential and future research directions.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
ObjectType-Review-3
content type line 23
Edited by: Duuamene Nyimanu, University of Kansas Medical Center, United States
These authors have contributed equally to this work and share first authorship
Ashish Dhayani, University of Pittsburgh, United States
Reviewed by: Hao Du, Yale University, United States
ISSN:1663-9812
1663-9812
DOI:10.3389/fphar.2025.1560567